Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Immunocore

IMCR

IMCR Immunocore NASDAQ
Add to watchlist
7.39
0.00 (0.00 %)
At close : Jan 03, 16:00 ET
--
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    IMCR Chart
    See on advanced chart >
    All
    D
    W
    M
    5m
    • Volume 190.74k
    • Turnover 1.39M
    • P/E(TTM) --
    • Turnover % 0.51%
    • P/E(Static) --
    • Market Cap 348.92M
    • P/B 2.76
    • Shares 47.21M
    • 52 Week Range
      5.81
      27.72
    • Day Range
      6.99
      7.62

    News

    Filings

    All
    Interim Statements
    Ownership
    SEC Inquiries
    Key Event

    About

    Immunocore Holdings plc was incorporated on January 7, 2021 under the laws of England and Wales.They are a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing...
    • Highlight
      A commercial-stage biotechnology company that developing immunotherapies with T-cell receptors to treat cancer, infectious and autoimmune
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      02/05/2021
    • Established Date
      01/07/2021
    • Full-time Employees
      497
    • Address
      92 Park Drive Milton Park Abingdon Oxfordshire OX14 4RY United Kingdom
    • Tel
      44-1235-438600
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      American Depositary Receipt (Common Stock)

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App
    All
    QUICK
    Daily
    Weekly
    Monthly
    Minutes
    5 minutes
    15 minutes
    30 minutes
    Ranges
    1 Day
    1 Week
    1 Month
    1 Year
    YTD